JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|||
339 | Tue, 8/2/2011, 10:30 AM - 12:20 PM | CC-C222 | |
Statistical Considerations in the Analysis of Progressive Free Survival — Topic Contributed Papers | |||
Biopharmaceutical Section , Section for Statistical Programmers and Analysts , Section on Statistics in Epidemiology | |||
Organizer(s): Jing Xu, Millennium Pharmaceuticals | |||
Chair(s): Satrajit Roychoudhury, Novartis | |||
10:35 AM | Predicting Analysis Time in Event-Driven Clinical Trials with Event-Reporting Lag — Jianming Wang, Novartis Oncology ; Chunlei Ke, Amgen Inc. ; Qi Jiang, Amgen Inc. ; Charlie Zhang, Exelixis ; Steve Snapinn, Amgen Inc. | ||
10:55 AM | The Effect of Periodic Follow-Up: Design and Analysis of Progression-Free Survival Data — Zhigang Zhang, MSKCC | ||
11:15 AM | Some Practical Issues in PFS Analysis from Industry Perspective — Jingyuan Wang, Millennium Pharmaceuticals ; Connie Lee, Millennium Pharmaceuticals ; Jing Xu, Millennium Pharmaceuticals ; Yuanjun Shi, Millennium Pharmaceuticals | ||
11:35 AM | Regulatory Considerations in the Evaluation of Progression-Free Survival — Rajeshwari Sridhara, U.S. Food and Drug Administration | ||
11:55 AM | Issues in the Analysis of Progression-Free Survival from a Cancer Clinical Trial — Dianne M. Finkelstein, Massachusetts General Hospital/Harvard School of Public Health | ||
12:15 PM | Floor Discussion |
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.